ArticleScientific reports2025

Retraction Note: Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin.

Manoj Garg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.